Taejon, South Korea

Chang-Ho Lee

This inventor holds 3 USPTO granted patents. Top assignee: Lg Life Sciences, Limited. Active years: 2007-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chang-Ho Lee. Retrieved from https://idiyas.com/inventor/chang-ho-lee-jwn7ste1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 15.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Yuseong-gu, KR (2007)
  • Taejeon, KR (2009 - 2010)

Company Filing History:


Years Active: 2007-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Chang-Ho Lee: A Pioneer in Antiviral Research

Introduction

Chang-Ho Lee, an esteemed inventor hailing from Taejeon, Korea, has made significant contributions to the field of antiviral research. With three patents to his name, his work primarily focuses on the development of novel compounds that could potentially combat serious viral infections, particularly hepatitis B virus.

Latest Patents

Lee's most recent patents include a breakthrough in acyclic nucleoside phosphonate derivatives. This innovative class of compounds is particularly noteworthy for its potential use as antiviral agents. The invention encompasses not only the derivatives but also pharmaceutically acceptable salts and the intricate processes for their preparation. These derivatives are designed to target the hepatitis B virus effectively, showcasing Lee's commitment to addressing pressing health challenges through his inventions.

Career Highlights

Throughout his career, Chang-Ho Lee has continuously explored and expanded the boundaries of medicinal chemistry. His affiliation with LG Life Sciences Limited has provided him with a platform to engage in cutting-edge research and bring his inventions to fruition. His meticulous approach to research and development has led to his recognition as a key player in the field of antiviral drugs.

Collaborations

During his innovative journey, Lee has collaborated with notable colleagues such as Jong-Ryoo Choi and Jeong-Min Kim. These teamwork dynamics have undoubtedly enriched his research experience, allowing for a collective effort in advancing antiviral therapeutics.

Conclusion

In summary, Chang-Ho Lee stands out as a prominent inventor whose contributions to antiviral research hold promise for better healthcare outcomes. With a solid foundation in acyclic nucleoside phosphonate derivatives and valuable collaborations, his work is poised to make a significant impact in the battle against viral infections. Lee's enduring pursuit of innovation serves as an inspiration for future generations of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…